Tiziana Life Sciences (TLSA) Competitors $1.90 -0.06 (-3.06%) Closing price 08/26/2025 04:00 PM EasternExtended Trading$1.88 -0.02 (-1.00%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLSA vs. SION, TRVI, URGN, CRON, IMNM, QURE, PGEN, AKBA, AVXL, and NRIXShould you be buying Tiziana Life Sciences stock or one of its competitors? The main competitors of Tiziana Life Sciences include Sionna Therapeutics (SION), Trevi Therapeutics (TRVI), Urogen Pharma (URGN), Cronos Group (CRON), Immunome (IMNM), uniQure (QURE), Precigen (PGEN), Akebia Therapeutics (AKBA), Anavex Life Sciences (AVXL), and Nurix Therapeutics (NRIX). These companies are all part of the "pharmaceutical products" industry. Tiziana Life Sciences vs. Its Competitors Sionna Therapeutics Trevi Therapeutics Urogen Pharma Cronos Group Immunome uniQure Precigen Akebia Therapeutics Anavex Life Sciences Nurix Therapeutics Tiziana Life Sciences (NASDAQ:TLSA) and Sionna Therapeutics (NASDAQ:SION) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Is TLSA or SION more profitable? Company Net Margins Return on Equity Return on Assets Tiziana Life SciencesN/A N/A N/A Sionna Therapeutics N/A N/A N/A Does the media favor TLSA or SION? In the previous week, Sionna Therapeutics had 4 more articles in the media than Tiziana Life Sciences. MarketBeat recorded 6 mentions for Sionna Therapeutics and 2 mentions for Tiziana Life Sciences. Tiziana Life Sciences' average media sentiment score of 1.31 beat Sionna Therapeutics' score of 1.08 indicating that Tiziana Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tiziana Life Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sionna Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer TLSA or SION? Sionna Therapeutics has a consensus price target of $38.50, indicating a potential upside of 52.66%. Given Sionna Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Sionna Therapeutics is more favorable than Tiziana Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tiziana Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sionna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, TLSA or SION? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTiziana Life SciencesN/AN/A-$11.86MN/AN/ASionna TherapeuticsN/AN/A-$61.69MN/AN/A SummarySionna Therapeutics beats Tiziana Life Sciences on 4 of the 6 factors compared between the two stocks. Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSA vs. The Competition Export to ExcelMetricTiziana Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$229.02M$3.07B$5.73B$9.74BDividend YieldN/A2.26%3.95%4.07%P/E RatioN/A20.5230.3326.09Price / SalesN/A352.87423.38106.20Price / CashN/A44.2437.7259.08Price / Book47.508.139.796.67Net Income-$11.86M-$54.08M$3.27B$265.43M7 Day Performance4.97%4.48%3.65%3.36%1 Month Performance2.15%3.64%3.83%0.39%1 Year Performance53.23%7.34%32.34%19.43% Tiziana Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSATiziana Life Sciences0.842 of 5 stars$1.90-3.1%N/A+54.5%$229.02MN/A0.008Positive NewsSIONSionna Therapeutics1.8942 of 5 stars$21.39+2.7%$38.50+80.0%N/A$918.99MN/A0.0035Positive NewsHigh Trading VolumeTRVITrevi Therapeutics2.8811 of 5 stars$7.45-0.9%$20.38+173.5%+149.0%$915.76MN/A-17.7420Positive NewsURGNUrogen Pharma4.5468 of 5 stars$19.40-1.6%$31.43+62.0%+36.5%$911.87M$90.40M-5.84200CRONCronos Group0.7891 of 5 stars$2.53+6.8%N/A+10.9%$907.80M$117.61M50.60450News CoverageIMNMImmunome1.569 of 5 stars$10.25-0.3%$23.14+125.8%-35.3%$894.82M$9.04M-3.3340Analyst ForecastQUREuniQure2.3991 of 5 stars$15.66-3.2%$37.45+139.2%+158.0%$887.75M$14.34M-3.99500Positive NewsPGENPrecigen3.8424 of 5 stars$2.95+0.3%$6.00+103.4%+270.4%$876.04M$3.92M-7.02190AKBAAkebia Therapeutics3.8147 of 5 stars$3.11-4.3%$6.75+117.0%+99.4%$861.72M$203.73M-18.29430Analyst RevisionAVXLAnavex Life Sciences3.734 of 5 stars$9.59-3.5%$44.00+358.8%+49.8%$854.21MN/A-16.8240News CoverageNRIXNurix Therapeutics2.5857 of 5 stars$10.20-3.6%$28.87+183.0%-62.9%$808.83M$54.55M-3.91300News CoveragePositive NewsHigh Trading Volume Related Companies and Tools Related Companies SION Competitors TRVI Competitors URGN Competitors CRON Competitors IMNM Competitors QURE Competitors PGEN Competitors AKBA Competitors AVXL Competitors NRIX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLSA) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredChase, Bank of America, Wells Fargo Preparing for BIG ChangeThanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in Am...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Tiziana Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access